Nvidia: Don't Be Fooled By The Naysayers
Seeking Alpha· 2024-11-26 21:30
JR Research is an opportunistic investor. He was recognized by TipRanks as a Top Analyst. He was also recognized by Seeking Alpha as a "Top Analyst To Follow" for Technology, Software, and Internet, as well as for Growth and GARP. He identifies attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. He has also demonstrated outperformance with his picks. He focuses on identifying growth investing opportunities that present the most attracti ...
Netcapital Secures FINRA Approval for Broker-Dealer License
GlobeNewswire News Room· 2024-11-26 21:30
BOSTON, MA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL, NCPLW) (the “Company”), a digital private capital markets ecosystem, today announced that its wholly-owned subsidiary, Netcapital Securities Inc. (“NSI”), has received approval from the Financial Industry Regulatory Authority ("FINRA") to become a FINRA-member broker-dealer. Key Highlights: Netcapital Securities Inc. is specifically approved to engage in the following types of business: private placements of securities and referr ...
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
GlobeNewswire News Room· 2024-11-26 21:30
ROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced its approval on contract for the Federal Supply Schedule (FSS), also known as the GSA Schedule, for the CompuFlo® Epidural System. This significant milestone follows the Company's earlier registration with the U.S. Government’s System for Award Management (SAM) in March 2023. The FSS designation p ...
Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders
GlobeNewswire News Room· 2024-11-26 21:30
MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that the Company will present at the at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders, taking place December 6-8, 2024, in Washington, DC. Presentation Name: The use of ...
Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
GlobeNewswire News Room· 2024-11-26 21:30
REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for DCCR (diazoxide choline) extended-release tablets for the treatment of Prader-Willi syndrome (PWS) in individuals four years and older who have hyperphagia. Th ...
TEN Ltd. Reports Profits for the Nine Months and Third Quarter Ended September 30, 2024 and Sets Dividend Date
GlobeNewswire News Room· 2024-11-26 21:30
Net income of $157 million or $4.62 per share for 2024 nine months 50% higher dividend distributions from 2023 at $1.50 per common share in total $0.90 to be paid in December 2024 30 vessels with new and extended charters at significantly higher rates - $1.8 Billion in Fleet Forward Contracted Revenue Dynamic growth and renewal – 21 vessels contracted/acquired within 2024 Efficient vessel management – 10% decrease in vessel operating expenses TST operates first private naval academy in Greece Healthy Mark ...
Asphalt Ridge Option Period to Acquire Remaining 17.75% Working Interest Extended to February 10, 2025
GlobeNewswire News Room· 2024-11-26 21:30
Bakersfield, CA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, today provided updates on its Asphalt Ridge Project in Uintah County, Utah. TPET announced on January 5, 2024, that it had secured an option (the “Option”) to acquire a 20% interest in a sweet (i.e., low sulfur content), heavy-oil and tar-sand development project at Asphalt Ridge, located near the town of Vernal in Uintah County, northeastern Utah. ...
NANO Nuclear Energy and Everstar Announce Successful Pilot to Advance AI-Driven Regulatory and Licensing Solutions for the Nuclear Energy Industry
GlobeNewswire News Room· 2024-11-26 21:30
New York, N.Y., Nov. 26, 2024 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear or “the Company”), a leading vertically integrated advanced nuclear energy and technology company developing portable clean nuclear energy solutions, and Everstar, a leader in artificial intelligence (AI)-powered compliance solutions, today announced the successful three-month pilot project aimed at addressing regulatory challenges in the nuclear sector focused on implementing Everstar’s AI solutions acro ...
HawkSearch Introduces New Conversational Search Feature
GlobeNewswire News Room· 2024-11-26 21:30
WOBURN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of AI-driven marketing technology, has launched Conversational Search, the latest addition to its HawkSearch platform. Powered by Generative AI through Smart Response, this innovation leverages natural language capabilities to transform ordinary searches into conversational interactions. Conversational Search empowers businesses to: Turn Searches into Quality Conversations: Engage users with intelligent resp ...
IBN Initiates Coverage of Kairos Pharma Ltd.
GlobeNewswire News Room· 2024-11-26 21:30
LOS ANGELES, Nov. 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, has selected IBN, a multifaceted financial news and publishing company for private and public entities, to spearhead its corporate communications efforts. Kairos Pharma’s development pipeline targets drug resistance and immune suppression, two critical barriers to effective cancer treatment. The company's flagship ...